Merck Wins US FDA Breakthrough Therapy Designation Status for Enpatoran in Lupus
Merck has received US Food and Drug Administration (FDA) Breakthrough Therapy Designation (BTD) for enpatoran in lupus patients with active skin manifestations, advancing a potential first approved treatment for cutaneous lupus.
Lupus | 09/07/2026 | By News Bureau
Rise in Autoimmune Diseases Reported Across Karnataka, Warn Experts
During Rheumatology Awareness Month, experts highlight increasing cases of autoimmune and rheumatology disorders in Bengaluru and smaller towns, stressing early diagnosis to prevent severe complications and delayed treatment outcomes.
Lupus | 21/04/2026 | By News Bureau | 134
Sanofi Names Montpellier Global Hub for Autoimmune Disease Research
Sanofi, in partnership with the Immun4Cure University Hospital Institute in Montpellier, has launched a Translational Centre of Excellence focused on developing treatments for autoimmune and inflammatory diseases. The centre aims to place patients at the core of R&D, spanning early research through advanced clinical trials.
Lupus | 16/10/2025 | By Dineshwori | 404
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy